v3.5.0.2
Financial Statement Details (Tables)
9 Months Ended
Sep. 30, 2016
Disclosure of Financial Statement Details [Abstract]  
Financial Statement Details
Financial Statement Details (in millions)
Short- Term Marketable Securities, Available-for-Sale
Short-term marketable securities, consisting solely of debt securities, were as follows:
 
September 30, 2016
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Estimated
Market
Value
U.S. government agencies
$
22.4

 
$

 
$

 
$
22.4

Corporate debt
3.2

 

 

 
3.2

Commercial paper
4.0

 

 

 
4.0

Total
$
29.6

 
$

 
$

 
$
29.6


 
December 31, 2015
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Estimated
Market
Value
U.S. government agencies
$
22.1

 
$

 
$

 
$
22.1

Corporate debt
4.9

 

 

 
4.9

Commercial paper
2.1

 

 

 
2.1

Total
$
29.1

 
$

 
$

 
$
29.1


As of September 30, 2016, the estimated market value of available-for-sale marketable securities with contractual maturities of up to one year and up to 18 months were $25.1 million and $4.5 million, respectively.
Inventory
 
September 30, 2016
 
December 31, 2015
Raw materials
$
17.5

 
$
16.0

Work-in-process
2.6

 
2.6

Finished goods
24.6

 
16.6

Total
$
44.7

 
$
35.2


Accounts Payable and Accrued Liabilities
 
September 30, 2016
 
December 31, 2015
Accounts payable trade
$
26.3

 
$
19.0

Accrued tax, audit, and legal fees
3.7

 
2.1

Clinical trials
0.6

 
0.7

Pharmacy rebates
6.9

 
4.0

Accrued other including warranty
21.1

 
13.1

Total
$
58.6

 
$
38.9





Accrued Warranty
Warranty costs are reflected in the consolidated statements of operations as product cost of sales. A reconciliation of our accrued warranty costs for the three and nine months ended September 30, 2016 and 2015 were as follows:
 
Three Months Ended 
 September 30,
 
Nine Months Ended 
 September 30,
 
2016
 
2015
 
2016
 
2015
Beginning balance
$
7.9

 
$
1.2

 
$
3.3

 
$
1.3

Charges to costs and expenses
5.2

 
1.9

 
18.7

 
4.9

Costs incurred
(4.8
)
 
(1.8
)
 
(13.7
)
 
(4.9
)
Ending balance
$
8.3

 
$
1.3

 
$
8.3

 
$
1.3



Other Liabilities
 
September 30, 2016
 
December 31, 2015
Financing lease obligations
$
6.0

 
$

Deferred rent
5.2

 
3.8

Other
2.8

 
0.1

Total
$
14.0

 
$
3.9

Short Term Marketable Securities, Available for Sale
Short- Term Marketable Securities, Available-for-Sale
Short-term marketable securities, consisting solely of debt securities, were as follows:
 
September 30, 2016
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Estimated
Market
Value
U.S. government agencies
$
22.4

 
$

 
$

 
$
22.4

Corporate debt
3.2

 

 

 
3.2

Commercial paper
4.0

 

 

 
4.0

Total
$
29.6

 
$

 
$

 
$
29.6


 
December 31, 2015
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Estimated
Market
Value
U.S. government agencies
$
22.1

 
$

 
$

 
$
22.1

Corporate debt
4.9

 

 

 
4.9

Commercial paper
2.1

 

 

 
2.1

Total
$
29.1

 
$

 
$

 
$
29.1


As of September 30, 2016, the estimated market value of available-for-sale marketable securities with contractual maturities of up to one year and up to 18 months were $25.1 million and $4.5 million, respectively.
Inventory
Inventory
 
September 30, 2016
 
December 31, 2015
Raw materials
$
17.5

 
$
16.0

Work-in-process
2.6

 
2.6

Finished goods
24.6

 
16.6

Total
$
44.7

 
$
35.2

Accounts Payable and Accrued Liabilities
Accounts Payable and Accrued Liabilities
 
September 30, 2016
 
December 31, 2015
Accounts payable trade
$
26.3

 
$
19.0

Accrued tax, audit, and legal fees
3.7

 
2.1

Clinical trials
0.6

 
0.7

Pharmacy rebates
6.9

 
4.0

Accrued other including warranty
21.1

 
13.1

Total
$
58.6

 
$
38.9

Accrued Warranty
Accrued Warranty
Warranty costs are reflected in the consolidated statements of operations as product cost of sales. A reconciliation of our accrued warranty costs for the three and nine months ended September 30, 2016 and 2015 were as follows:
 
Three Months Ended 
 September 30,
 
Nine Months Ended 
 September 30,
 
2016
 
2015
 
2016
 
2015
Beginning balance
$
7.9

 
$
1.2

 
$
3.3

 
$
1.3

Charges to costs and expenses
5.2

 
1.9

 
18.7

 
4.9

Costs incurred
(4.8
)
 
(1.8
)
 
(13.7
)
 
(4.9
)
Ending balance
$
8.3

 
$
1.3

 
$
8.3

 
$
1.3

Other Noncurrent Liabilities [Table Text Block]
Other Liabilities
 
September 30, 2016
 
December 31, 2015
Financing lease obligations
$
6.0

 
$

Deferred rent
5.2

 
3.8

Other
2.8

 
0.1

Total
$
14.0

 
$
3.9